Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jashin Wu and Donovan Kearns.
Jashin Wu
Connection Strength
6.135
Donovan Kearns
  1. Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic. J Drugs Dermatol. 2021 May 01; 20(5):582-583.
    View in: PubMed
    Score: 0.943
  2. Use of systemic therapies for psoriasis in the COVID-19 era. J Dermatolog Treat. 2021 Jan 28; 1-4.
    View in: PubMed
    Score: 0.926
  3. Reply to Letter to the Editor Regarding: "Applying to dermatology residency during the COVID-19 pandemic". J Am Acad Dermatol. 2021 01; 84(1):e31-e32.
    View in: PubMed
    Score: 0.906
  4. Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Dec; 83(6):e433-e434.
    View in: PubMed
    Score: 0.895
  5. Applying to dermatology residency during the COVID-19 pandemic. J Am Acad Dermatol. 2020 Oct; 83(4):1214-1215.
    View in: PubMed
    Score: 0.891
  6. Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic. J Am Acad Dermatol. 2020 09; 83(3):e251-e252.
    View in: PubMed
    Score: 0.886
  7. Understanding the Potential Role of Abrocitinib in the Time of SARS-CoV-2. J Drugs Dermatol. 2021 Jul 01; 20(7):806.
    View in: PubMed
    Score: 0.238
  8. Dermatologists as social media contributors during the COVID-19 pandemic. Cutis. 2020 11; 106(5):245-246.
    View in: PubMed
    Score: 0.228
  9. Clinical management of psoriasis patients during the COVID-19 pandemic. J Dermatolog Treat. 2020 Jun 22; 1-2.
    View in: PubMed
    Score: 0.222
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.